Claris Lifesciences has informed that the Buy Back Committee (constituted by the Board of Directors of the Company at its meeting held on January 07, 2014), at its meeting held on March 20, 2014, has approved April 02, 2014 as the record date for the purpose of determining the entitlement and the names of the equity shareholders, to whom the Letter of Offer and Tender Form will be sent and who are eligible to participate in the Buy Back up to 92,50,000 equity shares of face value of Rs 10 each at a price of Rs 250 per Equity Share payable in cash for an aggregate amount of Rs 231,25,00,000 from the equity shareholders/ beneficial owners of the Equity Shares of the Company as on the record date i.e. April 02, 2014.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: